-Hilde Rosing Researcher Activity Profile

Research Author Detailed Information 

Hilde Rosing Publication Rate By Year

Hilde Rosing has published 5 paper(s) in 2007, 3 paper(s) in 2008, for a total of 8 research publications in total.

Hilde H Rosing Author Information

LAST NAME: rosing

FIRST NAME: hilde

INITIALS: H

AFFILIATION:

Papers

Hilde Rosing's Publication Record

1. Quantitative and selective assay of 5-methylindirubine, an inhibitor of cyclin-dependent kinases, in murine plasma using coupled liquid chromatography and electrospray tandem mass spectrometry. Year Published: 2007
Department of Pharmacy & Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, 1066 EC Amsterdam, The Netherlands. liia.vainchtein@slz.nl
2. Knockout of cytochrome P450 3A yields new mouse models for understanding xenobiotic metabolism. Year Published: 2007
Division of Experimental Therapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
3. Development and validation of an assay for the quantitative determination of cladribine nucleotides in MDCKII cells and culture medium using weak anion-exchange liquid chromatography coupled with tandem mass spectrometry. Year Published: 2007
Department of Pharmacy & Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, 1066 EC Amsterdam, The Netherlands.
4. Quantitative aspects of the analysis of the monoclonal antibody trastuzumab using high-performance liquid chromatography coupled with electrospray mass spectrometry. Year Published: 2008
Department of Pharmacy & Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, 1066 EC Amsterdam, The Netherlands.
5. Development and validation of an assay for the quantitative determination of cladribine nucleotides in MDCKII cells and culture medium using weak anion-exchange liquid chromatography coupled with tandem mass spectrometry. Year Published: 2007
Department of Pharmacy & Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, Amsterdam, The Netherlands. robert.jansen@slz.nl
6. Enhanced resolution triple-quadrupole mass spectrometry for ultra-sensitive and quantitative analysis of the investigational anticancer agent EO9 (apaziquone) and its metabolite EO5a in human and dog plasma to support (pre)-clinical studies of EOquin(R) g? Year Published: 2008
Department of Pharmacy & Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, 1066 EC Amsterdam, The Netherlands.
7. Knockout of cytochrome P450 3A yields new mouse models for understanding xenobiotic metabolism. Year Published: 2007
Division of Experimental Therapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
8. Cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy with paclitaxel: a clinical and pharmacokinetic study. Year Published: 2008
Department of Surgical Oncology, University Hospital, Crete University Medical School, P.O. Box 1352, 71 110, Herakleion, Greece. debree@med.uoc.gr